[at Bloomberg] – Bristol-Myers Squibb Co. will try to grab an early share of the multibillion-dollar market for new hepatitis C treatments by piggybacking its experimental drug with Gilead Sciences Inc.’s approved pill….
Read more … [visit site to read more]
Gilead Sciences Inc. (NASDAQ:GILD) ~ Bristol-Myers Ties Hepatitis C Success to Gilead’s Pill
January 14, 2014 at 08:25 AM EST
[at Bloomberg] – Bristol-Myers Squibb Co. will try to grab an early share of the multibillion-dollar market for new hepatitis C treatments by piggybacking its experimental drug with Gilead Sciences Inc.’s approved pill…. . . . → Read More: Gilead Sciences Inc. (NASDAQ:GILD) ~ Bristol-Myers Ties Hepatitis C Success to Gilead’s Pill